MedPath

Spartan Cube CYP2C19 Method Comparison Study

Not Applicable
Completed
Conditions
Genotyping Techniques
Interventions
Device: Spartan Cube CYP2C19 System
Registration Number
NCT04473586
Lead Sponsor
Spartan Bioscience Inc.
Brief Summary

The aim of the study is to demonstrate concordance (percent agreement) between results produced by the Spartan CYP2C19 system and bi-directional sequencing. In addition, this study will evaluate the concordance of buccal samples stored prior to running on the Spartan Cube CYP2C19 system and bi-directional sequencing.

Detailed Description

Sample holding time - two parts

1. Sample tested in less than one-hour

a.In the first part, buccal samples will be collected from subjects and tested using the Spartan Cube CYP2C19 system. These samples will be run immediately (within 1 h) after collection from the subject (\<1 h sample holding time). All results will be compared to bi-directional sequencing to determine percent agreement.

2. Sample tested greater than 21 hours a.In the second part (sample holding portion), samples will be tested using the Spartan Cube CYP2C19 product. These samples will be run after storage at ambient temperature. All results will be compared to bi-directional sequencing to determine the percent agreement.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
425
Inclusion Criteria
  • Participants who will provide buccal samples and a saliva sample who have not eaten drank or smoked in the past 30 minutes.
Exclusion Criteria
  • Participants who have eaten drank or smoked in the past 30 minutes prior to collection.

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
Samples tested greater than 24 hoursSpartan Cube CYP2C19 SystemBuccal samples will be collected, stored and then analyzed on the Spartan Cube CYP2C19 System greater than 24 hours after collection. The Spartan Cube CYP2C19 results will be compared with bi-directional sequencing results generated by a third part from a saliva sample collected from the same subject.
Sample tested in less than one-hourSpartan Cube CYP2C19 SystemBuccal samples will be collected and analyzed on the Spartan Cube CYP2C19 System immediately (\<1hr). The Spartan Cube CYP2C19 results will be compared with bi-directional sequencing results generated by a third part from a saliva sample collected from the same subject.
Primary Outcome Measures
NameTimeMethod
% Agreement of test results generated on the Spartan Cube CYP2C19 System and bidirectional sequencingThrough study completion; anticipated to be less than 4 months

Determine % agreement across all tests conducted and bi-directional sequencing results

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Mount Sinai Services

🇨🇦

Toronto, Ontario, Canada

© Copyright 2025. All Rights Reserved by MedPath